<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455960</url>
  </required_header>
  <id_info>
    <org_study_id>Arginine 01</org_study_id>
    <nct_id>NCT02455960</nct_id>
  </id_info>
  <brief_title>Protective Effects of Oral L-Arginine CI-AKI</brief_title>
  <official_title>Protective Effects of Oral L-Arginine Supplement in Patients With CKD After Intravenous Contrast Media Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phramongkutklao College of Medicine and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phramongkutklao College of Medicine and Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial was performed to examine the efficacy of oral L-arginine for preventing CI-AKI in
      chronic kidney disease (CKD) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contrast-induced acute kidney injury (CI-AKI) is a common complication in hospitalized
      patients. Nitric oxide-signal transduction plays an important role in prevention of CI-AKI.
      L-Arginine is an amino acid involved in ammonia detoxification, and is well known as a
      precursor to nitric oxide, a key component of endothelial-derived relaxing factor.

      This is a prospective randomized, double blind, placebo controlled trial among CKD stage 3-4
      patients undergoing computer tomography. Eligible patients were randomly assigned to two
      groups: (1) arginine 3 g/day or 6 capsules per day, and (2) placebo 6 capsules per day for 3
      days before contrast media injection. Serum cystatin C, serum creatinine and estimated GFR
      was measured at baseline and 48 hours after procedure.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Contrast-induced acute kidney injury (CI-AKI)</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse effects</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Contrast Induced AKI</condition>
  <arm_group>
    <arm_group_label>Arginine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants need to take arginine 3 g/day orally for 3 days before CT with contrast media injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants need to take placebo (corn powder) 3 g/day orally for 3 days before CT with contrast media injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-arginine</intervention_name>
    <description>Comparison of the efficacy of L-arginine 3 grams for days versus placebo in contrast induced AKI prevention</description>
    <arm_group_label>Arginine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Stable CKD stage 3-4 patients

          -  Patients undergoing elective contrast media injection

        Exclusion Criteria:

          -  History of arginine allergy

          -  Acute kidney injury diagnosed within 4 weeks

          -  Active infection/sepsis

          -  Severe liver disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division of Nephrology, Phramongkutklao Hospital</name>
      <address>
        <city>Rachatevee</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuttawut Siritaweesuk, MD.</last_name>
      <phone>66819019191</phone>
      <email>znak.iiz@gmaill.com</email>
    </contact>
    <investigator>
      <last_name>Nuttawut Siritaweesuk, MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2015</study_first_submitted>
  <study_first_submitted_qc>May 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>May 27, 2015</last_update_submitted>
  <last_update_submitted_qc>May 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

